Intermolecular Appoints Chris Kramer President and CEO

Go back to Intermolecular Appoints Chris Kramer President and CEO

Intermolecular (IMI) Reports In-Line Q2 EPS; Issues Light Q3 Outlook

August 5, 2016 6:35 AM EDT

Intermolecular (NASDAQ: IMI) reported Q2 EPS of ($0.06), in-line with the analyst estimate of ($0.06). Revenue for the quarter came in at $11.7 million versus the consensus estimate of $12.2 million.

GUIDANCE:

Intermolecular sees Q3 2016 EPS of ($0.12)-($0.10), versus the consensus of ($0.03). Intermolecular sees Q3... More